๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

A review of transfer factor immunotherapy in cancer

โœ Scribed by Albert F. Lobuglio; James A. Neidhart


Publisher
John Wiley and Sons
Year
1974
Tongue
English
Weight
697 KB
Volume
34
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Adjuvant immunotherapy of primary resect
โœ Takehiko Fujisawa; Yutaka Yamaguchi; Hideki Kimura; Masaaki Arita; Masayuki Baba ๐Ÿ“‚ Article ๐Ÿ“… 1984 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 596 KB

One hundred seventy-one patients were studied in order to evaluate the clinical efficacy of the transfer factor (TF) for primary resected lung cancers under a randomized controlled trial. Eligible cases for evaluation were randomly chosen at 75 and 74 patients in TF and control groups, respectively.

Monitoring of circulating angiogenic fac
โœ Christine Brostjan; Anita Bayer; Anna Zommer; Alexander Gornikiewicz; Sebastian ๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 147 KB

## Abstract ## BACKGROUND A promising treatment approach for patients with malignant disease that recently has found its way into clinical trials is based on vaccination with autologous dendritic cells loaded with tumor antigens. However, adequate assays for monitoring clinical and immunologic res

Transfer factor therapy in patients with
โœ R. Mark Vetto; Denis R. Burger; James E. Nolte; Arthur A. Vandenbark; Harvey W. ๐Ÿ“‚ Article ๐Ÿ“… 1976 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 712 KB

The objective of this study was to utilize transfer factor to stimulate cell-mediated immunity to specific tumor antigens in cancer patients. Thirty-five selected patients with advanced recurrent cancer, who were not suitable for further conventional therapy, were treated with transfer factor. Trans

A contemporary review of sublingual immu
โœ Elina Toskala ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 75 KB

## Abstract The sublingual route has become an interesting and novel therapeutic option for the immunotherapeutic management of patients with allergies. Immunotherapy modifies the immune response by decreasing the specific IgE levels and Th2โ€type inflammation in the mucosa when allergen exposure oc